Omeros Corporation
OMER
#6443
Rank
C$1.06 B
Marketcap
C$14.99
Share price
-1.63%
Change (1 day)
-3.69%
Change (1 year)

Earnings for Omeros Corporation (OMER)

Earnings in 2025 (TTM): -C$0.18 Billion

According to Omeros Corporation's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -C$0.22 Billion a decrease over its 2023 earnings that were of -C$0.2 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Omeros Corporation from 2009 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$0.18 Billion-19.07%
2024 -C$0.22 Billion9.63%
2023 -C$0.2 Billion-9.57%
2022 -C$0.23 Billion-30.65%
2021 -C$0.32 Billion86.28%
2020 -C$0.18 Billion99.45%
2019 -C$85.42 Million-49.91%
2018 -C$0.18 Billion190.77%
2017 -C$58.65 Million-27.96%
2016 -C$81.41 Million-17.61%
2015 -C$98.81 Million1.88%
2014 -C$96.99 Million87.56%
2013 -C$51.71 Million
2011 -C$37.87 Million-8.96%
2010 -C$41.6 Million45.03%
2009 -C$28.68 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eterna Therapeutics
ERNA
-C$13.11 Million-92.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
-C$5.34 Million-96.94%๐Ÿ‡ฆ๐Ÿ‡บ Australia
Pfizer
PFE
C$16.37 B-9,490.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$44.75 B-25,768.33%๐Ÿ‡บ๐Ÿ‡ธ USA